2024³â ´ëÇѽÉÀåÇÐȸ ÁߺÎÁöȸ Ãá°è Çмú´ëȸ : 2024-04-13
±³À°ÀÏÀÚ : 2024-04-13
±³À°Àå¼Ò : C&V¼¾ÅÍ Ä¿¹Â´ÏÄÉÀ̼Ǽ¾ÅÍ 2Ãþ ´ëȸÀǽÇ
±³À°ÁÖÁ¦ : 2024³â ´ëÇѽÉÀåÇÐȸ ÁߺÎÁöȸ Ãá°è Çмú´ëȸ
ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ÁߺÎÁöȸ
´ã´çÀÚ : ¹ÚÁÖÈ
¿¬¶ôó : 043-269-8831
À̸ÞÀÏ : coin317@naver.com
±³À°Á¾·ù : ³»°ú, ÈäºÎ¿Ü°ú
Âü¼®¿¹»óÀÎ : 100¸í
Èñ¸ÁÆòÁ¡ : 6Á¡
Áö¿ª : ÃæûºÏµµ
±³À°½Ã°£ : 7 ½Ã°£ 15ºÐ
¼¼ºÎ¼ö°·á : 10,000¿ø
ºñ°í
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±³À°½Ã°£ 04¿ù 13ÀÏ ´ëȸÀÇ½Ç 09:10~09:30 2023 AHA/ACC AF guideline focus ±è¹Î(ÃæºÏÀÇ´ë)
±³À°½Ã°£ 04¿ù 13ÀÏ ´ëȸÀÇ½Ç 09:30~09:50 Wearable ECG monitoring device in clinical practice ÃÖÇÏ¿µ(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 04¿ù 13ÀÏ ´ëȸÀÇ½Ç 09:50~10:10 How to do left bundle branch area pacing ȲÁ¾¹Î(°è¸íÀÇ´ë)
Åä·Ð 04¿ù 13ÀÏ ´ëȸÀÇ½Ç 10:10~10:30 Discussion ±è¹Î¼ö ¿Ü 4ÀÎ(Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 04¿ù 13ÀÏ ´ëȸÀÇ½Ç 10:30~10:50 Why Intravascular Imaging Should Be Used in Clinical Practice, Review from Evidence À¯Áö¿õ(´Ü±¹ÀÇ´ë)
±³À°½Ã°£ 04¿ù 13ÀÏ ´ëȸÀÇ½Ç 10:50~11:10 Equipment for CTO PCI and Basic Guidewire skills ±è´ë¿ø(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 04¿ù 13ÀÏ ´ëȸÀÇ½Ç 11:10~11:30 Management for Endoleak (type I & II) in AAA stent graft ±è»ó¹Î(ÃæºÏÀÇ´ë)
±³À°½Ã°£ 04¿ù 13ÀÏ ´ëȸÀÇ½Ç 11:30~11:50 Moderate Aortic Stenosis, Moderate Risk Patients: Expanding TAVR ¾ÈÁöÈÆ(À»ÁöÀÇ´ë)
Åä·Ð 04¿ù 13ÀÏ ´ëȸÀÇ½Ç 11:50~12:00 Discussion ¹Ú»óÈ£ ¿Ü 5ÀÎ(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 04¿ù 13ÀÏ ´ëȸÀÇ½Ç 12:00~12:20 Optimal BP control with antihypertensive drug treatment Á¤¿µÇÐ(´Ü±¹ÀÇ´ë)
Åä·Ð 04¿ù 13ÀÏ ´ëȸÀÇ½Ç 12:00~12:30 Discussion ¼¿µÈÆ ¿Ü 5ÀÎ(°Ç¾çÀÇ´ë)
ÈÞ½Ä 04¿ù 13ÀÏ ´ëȸÀÇ½Ç 12:30~12:50 ÈÞ½Ä ()
±³À°½Ã°£ 04¿ù 13ÀÏ ´ëȸÀÇ½Ç 12:50~13:10 New drug in Heart Failure –Vericiguat, Omecamtiv ±èÈñµ¿(¼øõÇâÀÇ´ë)
±³À°½Ã°£ 04¿ù 13ÀÏ ´ëȸÀÇ½Ç 13:10~13:30 LVAD in Acute/Chronic heart failure Áø¼±¾Æ(Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 04¿ù 13ÀÏ ´ëȸÀÇ½Ç 13:30~13:50 Heart transplantation: Best timing for better outcome À̼±È(°è¸íÀÇ´ë)
Åä·Ð 04¿ù 13ÀÏ ´ëȸÀÇ½Ç 13:50~14:00 Discussion ±è±âÈ« ¿Ü 5ÀÎ(°Ç¾çÀÇ´ë)
±³À°½Ã°£ 04¿ù 13ÀÏ ´ëȸÀÇ½Ç 14:00~14:35 Cardiac sarcoidosis update ¼ÛÀç°ü(¿ï»êÀÇ´ë)
Åä·Ð 04¿ù 13ÀÏ ´ëȸÀÇ½Ç 14:35~14:50 Discussion ÃÖÀ¯Á¤ ¿Ü 5ÀÎ(À»ÁöÀÇ´ë)
±³À°½Ã°£ 04¿ù 13ÀÏ ´ëȸÀÇ½Ç 15:00~15:20 2023 ESC Hypertension Clinical GuidelineÀº ±¹³» °íÇ÷¾Ð Áø·áÁöħ°ú ºñ±³ÇÏ¿© ¾î¶»°Ô ´Þ¶óÁ³À»±î? À̱Լ·(°¡Å縯ÀÇ´ë)
±³À°½Ã°£ 04¿ù 13ÀÏ ´ëȸÀÇ½Ç 15:20~15:40 Àü°øÀǵéÀ» À§ÇÑ ½ÉÇ÷°ü Á¶¿µ¼ú ÀÌÇØÇϱ⠼º¼®¿ì(Ãæ³²ÀÇ´ë)
±³À°½Ã°£ 04¿ù 13ÀÏ ´ëȸÀÇ½Ç 15:40~16:00 Àü°øÀǵéÀ» À§ÇÑ ½ÉÃÊÀ½ÆÄ·Î ÆǸ·Áúȯ ÀÌÇØÇϱâ À̼ö¿¬(´Ü±¹ÀÇ´ë)
±³À°½Ã°£ 04¿ù 13ÀÏ ´ëȸÀÇ½Ç 16:00~16:20 Àü°øÀǵéÀÌ ³õÄ¡±â ½¬¿î ½ÉÀüµµ ±ÇÈñÁø(Ãæ³²ÀÇ´ë)
Åä·Ð 04¿ù 13ÀÏ ´ëȸÀÇ½Ç 16:20~16:35 Discussion ¾ÈÁöÈÆ ¿Ü 5ÀÎ(À»ÁöÀÇ´ë)